POINT Biopharma Global In... (PNT)
NASDAQ: PNT
· Real-Time Price · USD
12.50
0.02 (0.16%)
At close: Dec 26, 2023, 10:00 PM
POINT Biopharma Global Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 21.61M | 57.29M | 111.14M | 286.43M | 125.78M | 78.11M | 227.39M | 238.82M | 252.83M | 273.74M | 699.53K |
Short-Term Investments | 317.56M | 365.93M | 318.89M | 238.78M | 165.74M | 121.32M | n/a | n/a | n/a | n/a | 135.71M |
Long-Term Investments | 59.79M | 11.57M | 89.17M | 16.12M | n/a | 4.9M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 5.12M | 5.03M | -123.94M | -47.5M | -29.46M | n/a | n/a | n/a | n/a | n/a | 135.71M |
Receivables | 9.39M | 3.73M | 159.04K | 60.22K | 169.61K | 143.1K | 90.03K | 72.67K | 48.62K | 31.49K | n/a |
Inventory | 4.2M | 5.2M | 4.2M | 5.34M | 4.32M | 5.14M | 4.87M | 4.85M | 6.25M | 7.98M | n/a |
Other Current Assets | 492.79K | 217.32K | 189.28K | 215.2K | 220.75K | 191K | 271.91K | 105.45K | 173.06K | 64.6K | 88.82K |
Total Current Assets | 353.25M | 432.38M | 434.58M | 530.82M | 296.23M | 204.91M | 232.61M | 243.85M | 259.29M | 281.81M | 788.35K |
Property-Plant & Equipment | 59.55M | 48.8M | 34.77M | 31.38M | 29.46M | 24.44M | 20.37M | 19.41M | 17.9M | 15.65M | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 124.46M | 65.4M | 123.94M | 47.5M | 29.46M | 29.34M | 20.37M | 19.41M | 17.9M | 15.65M | 135.71M |
Total Assets | 477.7M | 497.77M | 558.52M | 578.32M | 325.69M | 234.24M | 252.98M | 263.26M | 277.2M | 297.46M | 136.5M |
Account Payables | 8.89M | 13.9M | 15.92M | 7.68M | 3.2M | 8.07M | 6.12M | 1.74M | 3.22M | 5.02M | 352.74K |
Deferred Revenue | 12.59M | 15.9M | 16.52M | 23.24M | n/a | n/a | n/a | n/a | n/a | 189.37K | n/a |
Short-Term Debt | 1.93M | 1.26M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.56M | n/a |
Other Current Liabilities | 15.27M | 10.1M | 45.41M | 48.82M | 13.41M | 10.73M | 7.52M | 6.24M | 4.88M | 3.15M | 5.5M |
Total Current Liabilities | 38.67M | 41.16M | 77.85M | 79.74M | 16.61M | 18.8M | 13.64M | 7.98M | 8.09M | 11.91M | 5.86M |
Long-Term Debt | 8.74M | 4.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 2.39M | 1.45M | 1.45M | 1.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 14.85M | 9.17M | 8.9M | 11.63M | 3.2M | 65.59K | 65.59K | 65.59K | 62.72K | 62.72K | 4.75M |
Total Liabilities | 53.51M | 50.32M | 86.74M | 91.37M | 16.61M | 18.86M | 13.71M | 8.05M | 8.16M | 11.97M | 5.86M |
Total Debt | 10.66M | 5.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.56M | n/a |
Common Stock | 10.58K | 10.58K | 10.57K | 10.56K | 10.4K | 9.01K | 9.01K | 9.01K | 9.01K | 9.01K | 125.64M |
Retained Earnings | -27.71M | -2.93M | 22.48M | 39.01M | -124.26M | -100.25M | -75.67M | -59.28M | -45.09M | -27.97M | -1.71M |
Comprehensive Income | -1.43M | -1.07M | -255.56K | -456.85K | -608.7K | -342.38K | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 424.19M | 447.45M | 471.78M | 486.95M | 309.08M | 215.38M | 239.27M | 255.21M | 269.04M | 285.49M | 130.64M |
Total Investments | 377.35M | 377.5M | 408.06B | 238.78M | 165.74M | 126.22M | n/a | n/a | n/a | n/a | 135.71M |